Development and evaluation of a ceMDCT-based preoperative risk stratification model to predict disease-free survival after radical surgery in patients with gastric cancer

[1] Ychou M(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721

[2] Cunningham D(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20

[3] Smyth EC(2016)Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v38-v49

[4] Wang FH(2019)The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer Cancer Commun (Lond) 39 10-19

[5] Association Japanese Gastric Cancer(2017)Japanese gastric cancer treatment guidelines 2014(ver. 4) Gastric Cancer 20 1-129

[6] Bando E(2019)Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer Gastric Cancer 22 123-289

[7] Reddavid R(2018)Neoadjuvant chemotherapy for gastric cancer Is it a must or a fake? World J Gastroenterol 24 274-904

[8] Park S(2017)Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication J Nucl Med 58 899-267

[9] Cheng J(2019)CT-detected extramural vessel invasion and regional lymph node involvement in stage T4a gastric cancer for predicting progression-free survival Am J Roentgenol 203 258-236

[10] Huang JY(2016)Borrmann type IV gastric cancer should be classified as pT4b disease J Surg Res 95 229-1369

[1] Ychou M(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721

[2] Cunningham D(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20

[3] Smyth EC(2016)Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v38-v49

[4] Wang FH(2019)The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer Cancer Commun (Lond) 39 10-19

[5] Association Japanese Gastric Cancer(2017)Japanese gastric cancer treatment guidelines 2014(ver. 4) Gastric Cancer 20 1-129

[6] Bando E(2019)Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer Gastric Cancer 22 123-289

[7] Reddavid R(2018)Neoadjuvant chemotherapy for gastric cancer Is it a must or a fake? World J Gastroenterol 24 274-904

[8] Park S(2017)Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication J Nucl Med 58 899-267

[9] Cheng J(2019)CT-detected extramural vessel invasion and regional lymph node involvement in stage T4a gastric cancer for predicting progression-free survival Am J Roentgenol 203 258-236

[10] Huang JY(2016)Borrmann type IV gastric cancer should be classified as pT4b disease J Surg Res 95 229-1369